Economic burden of contrast-induced nephropathy: implications for prevention strategies

References

• Rich MW, Crecelius CA. Incidence, risk factors and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Archives of Internal Medicine 1990; 150: 1237–1242.
   PubMedGoogle Scholar
• Tumlin J, Stacul F, Adam A et al. Pathophysiology of contrast-induced nephropathy. American Journal of Cardiology 2006; 98(6A): 14K–20K.
   Google Scholar
• Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. Journal of the American Medical Association 1996; 275: 1489–1494.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Wolyn R, Rocher LL et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. American Journal of Medicine 1997; 103: 368–375.
   PubMed Web of Science ®Google Scholar
• Powe NR, Moore RD, Steinberg EP. Adverse reactions to contrast media: factors that determine the cost of treatment. American Journal of Roentgenology 1993; 161: 1089–1095.
   Google Scholar
• Powe NR, AJ Davidoff, RD Moore et al. Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography. Journal of the American College of Cardiology 1993; 21: 101–109.
   Google Scholar
• Caro JJ, Trindade E, McGregor M. The cost- effectiveness of replacing high-osmolality with low-osmolality contrast media. American Journal of Roentgenology 1992; 159: 869–874.
   Google Scholar
• Barrett BJ, Parfrey PS, Foley RN et al. An economic analysis of strategies for the use of contrast media for diagnostic cardiac catheterization. Medical Decision Making 1994; 14: 325–335.
   Google Scholar
• Steinberg EP, Moore RD, Powe NR et al. Safety and cost effectiveness of high- osmolality as compared with low- osmolality contrast material in patients undergoing cardiac angiography. New England Journal of Medicine 1992; 326: 425–430.
   Google Scholar
• Aspelin P, Aubry P, Fransson SG et al. Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathy. American Heart Journal 2000; 149: 298–303.
   Google Scholar
• Mehran R, Aymong ED, Nikolsky E et al. A simple risk score for prediction of contrast- induced nephropathy after percutaneous coronary intervention: development and initial validation. Journal of the American College of Cardiology 2004; 44: 1393–1399.
   PubMed Web of Science ®Google Scholar
• Josephson SA, Dillon WP, Smith WS. Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging. Neurology 2005; 64: 1805–1806.
   PubMed Web of Science ®Google Scholar
• Bartholomew BA, Harjai KJ, Dukkipati S et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. American Journal of Cardiology 2004; 93: 1515–1519.
   PubMed Web of Science ®Google Scholar
• Mueller C, Buerkle G, Perruchoud AP et al. Female sex and risk of contrast nephropathy after percutaneous coronary intervention. Canadian Journal of Cardiology 2004; 20: 505–509.
   Google Scholar
• Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 165: 2259–2264.
   Google Scholar
• Dangas G, Iakovou I, Nikolsky E et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. American Journal of Cardiology 2005; 95: 13–19.
   PubMed Web of Science ®Google Scholar
• Lindsay J, Apple S, Pinnow EE et al. Percutaneous coronary intervention- associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheterization and Cardiovascular Interventions 2003; 59: 338–343.
   PubMed Web of Science ®Google Scholar
• Iakovou I, Dangas G, Mehran R et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. Journal of Invasive Cardiology 2003; 15: 18–22.
   PubMedGoogle Scholar
• Aspelin P, Aubry P, Fransson SG et al; Nephrotoxicity in High-Risk Patients Study of Iso-Osmolar and Low-Osmolar Non- Ionic Contrast Media Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. New England Journal of Medicine 2003; 348: 491–499.
   PubMed Web of Science ®Google Scholar
• Rudnick MR, JS Berns, RM Cohn et al. Contrast media-associated nephrotoxicity. Seminars in Nephrology 1997; 17: 15–26.
   Google Scholar
• Parfrey PS, Griffiths SM, Barrett BJ et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. New England Journal of Medicine 1989; 320: 143–149.
   PubMed Web of Science ®Google Scholar
• Gruberg L, Mintz GS, Mehran R et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. Journal of the American College of Cardiology 2000; 36: 1542–1548.
   PubMed Web of Science ®Google Scholar
• Gruberg L, Mehran R, Dangas G et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheterization and Cardiovascular Interventions 2001; 52: 409–416.
   PubMed Web of Science ®Google Scholar
• Nikolsky E, Mehran R. Understanding the consequences of contrast induced nephropathy. Reviews in Cardiovascular Medicine 2003; 4(Suppl. 5): S10–S18.
   Google Scholar
• Iakovou I, Dangas G et al. Incidence, predictors, and economic impact of contrast induced nephropathy: results in 8,628 patients treated with percutaneous coronary interventions. Journal of the American College of Cardiology 2002; 39(Suppl. 1): 2–2(1).
   Google Scholar
• Kugelmass AD, Cohen DJ, Brown PP et al. Hospital resources consumed in treating complications associated with percutaneous coronary interventions. American Journal of Cardiology 2006; 97: 322–327.
   PubMed Web of Science ®Google Scholar
• Subramanian S, Khandker R, Roth D. Long-term resource use and cost of percutaneous transluminal coronary angioplasty versus stenting in the elderly: a retrospective claims data analysis. Value in Health 2003; 6: 534–541.
   Google Scholar
• Shih YT, Guo A, Just PM et al. Impact of initial dialysis modality and modality switches on Medicare expenditures of end stage renal disease patients. Kidney International 2005; 68: 319–329.
   PubMed Web of Science ®Google Scholar
• Candrilli S, Mauskopf J. How much does a hospital day cost? 11th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR); 2006; Philadelphia, PA, USA.
   Google Scholar
• Zirogiannis PN, Rentoukas EI, Lazaros GA. Contrast media induced nephropathy in patients undergoing cardiac catheterisation. Hellenic Journal of Cardiology 2004; 45: 107–113.
   Google Scholar
• Soloman R, Barrett B. Follow-up of patients with contrast-induced nephropathy. Kidney International. Supplement 2006; 100: S46–S50.
   Google Scholar